ArticleBMJ open2020

Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver disease.

Changjun Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.